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Abstract
Background: The zitter (zi/zi) rat, a loss-of-function mutant of the glycosylated transmembrane protein attractin
(atrn), exhibits widespread age-dependent spongiform degeneration, hypomyelination, and abnormal metabolism
of reactive oxygen species (ROS) in the brain. To date, the mechanisms underlying these phenotypes have
remained unclear.
Results: Here, we show differentiation defects in zi/zi oligodendrocytes, accompanied by aberrant extension of
cell-processes and hypomyelination. Axonal bundles were relatively preserved during postnatal development.
With increasing in age, the injured oligodendrocytes in zi/zi rats become pathological, as evidenced by the
accumulation of iron in their cell bodies. Immunohistochemical analysis revealed that atrn expression was absent
from an oligodendrocyte lineage, including A2B5-positive progenitors and CNPase-positive differentiated cells.
The number and distribution of Olig2-positive oligodendrocyte progenitors was unchanged in the zi/zi brain.
Furthermore, an in vitro differentiation assay of cultured oligodendrocyte progenitors prepared from zi/zi brains
revealed their normal competence for proliferation and differentiation into mature oligodendrocytes.
Interestingly, we demonstrated the accelerated recruitment of ED1-positive macrophages/microglia to the
developing zi/zi brain parenchyma prior to the onset of hypomyelination. Semiquantitative RT-PCR analysis
revealed a significant up-regulation of CD26 and IL1-β in the zi/zi brain during this early postnatal stage.
Conclusion: We demonstrated that the onset of the impairment of oligodendrocyte differentiation occurs in a
non-cell autonomous manner in zi/zi rats. Hypomyelination of oligodendrocytes was not due to a failure of the
intrinsic program of oligodendrocytes, but rather, was caused by extrinsic factors that interrupt oligodendrocyte
development. It is likely that macrophage/microglial activation in the zi/zi  CNS leads to disturbances in
oligodendrocyte differentiation via deleterious extrinsic factors, such as the cytokine IL1-β or ROS. Atrn might
be involved in the activation of brain macrophages/microglia by suppressing excessive migration of monocytes into
the CNS, or by accelerating the transformation of brain monocytes into resting microglia. Understanding the
pathogenesis of the zi/zi  rat may provide novel insights into the developmental interaction betweens
macrophages/microglia and cells of an oligodendrocyte lineage.
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Background
Emerging evidence suggests that glial cells play an impor-
tant role in the onset of several neurodegenerative disor-
ders, including multiple system atrophy (MSA),
Alzheimer dementia (AD), Parkinson's dementia (PD)
and multiple sclerosis (MS). These diseases are character-
ized by iron deposition in oligodendrocytes, reactive oxy-
gen species (ROS)-mediated oxidative stress, and
neuroinflammation accompanied by macrophage/micro-
glial activation in the CNS [1-3].
The zitter (zi/zi) rat is an autosomal recessive spontaneous
mutant, the phenotype of which includes curled body
hair, bent whiskers, fine tremor that develops at 3 weeks
of age, and flaccid paresis of the hind limb at around 6
months of age [4]. It has been reported that the levels of
ROS production and oxidative stress are abnormally ele-
vated within the zi/zi brain [5,6]. Our previous studies
suggested that there was a prominent degeneration of
dopaminergic neurons in the zi/zi  rat substantia nigra
owing to increased oxidative stress with age [7-9], similar
to the degeneration observed in human PD. Pathologi-
cally, the zi/zi rat brain exhibits severe spongiform degen-
eration and hypomyelination, which is frequently
associated with abnormal membranous structures in oli-
godendrocytes [10]. A previous study demonstrated that
the commencement of myelination was not delayed in zi/
zi rats compared with control rats, and that the fundamen-
tal structures of myelin sheaths are normal in the zi/zi rat
during the postnatal period [11]. In addition, the bio-
chemical components of myelin, such as myelin basic
protein (MBP), proteolipid protein (PLP) and myelin-
associated glycoprotein (MAG), are normally expressed
[11]. Ultrastructural studies have indicated that the hypo-
myelination of zi/zi rats is characterized by a decrease in
the density of myelinated fibers as well as aberrant split
myelin lamellae in the ventral column of the cervical spi-
nal cord and in the optic nerve [10,11]. Gross pathologi-
cal changes in these regions, including vacuole formation
and degeneration of myelin sheaths into condensed sphe-
roids, appeared from 3 weeks of age in zi/zi rats [10,12].
However, curiously, the incidence of these membranous
abnormalities was shown to be quite low; they were seen
in only about 5% of the oligodendrocytes in random elec-
tron microscopic observations [12]. Consistently, our pre-
vious electron microscopic study failed to detect any
degenerative changes in the oligodendrocytes in the sub-
stantia nigra of zi/zi rats until postnatal 4 weeks [9].
A positional cloning study revealed that the zi/zi mutant
phenotype is due to a severe decrease in the level of attrac-
tin (atrn) mRNA expression as a consequence of an 8-bp
deletion at the splice donor site of the gene [13]. Attractin/
mahogany (atrn) mRNA encodes a transmembrane protein
containing a C-type lectin domain and four EGF-like
motifs, suggesting a function in intercellular interactions
through its downstream signaling [14]. Atrn  also pos-
sesses a CUB (C1r/C1s/Urinary epidermal growth factor,
Bone morphogenetic protein) domain, which is found
almost exclusively in extracellular and plasma membrane-
associated proteins. Many CUB domain-containing pro-
teins are proteases, although the roles of the CUB domain
have been largely unexplored [15]. In the CNS, although
previous  in situ hybridization studies have indicated a
ubiquitous distribution of the atrn mRNA in the adult
rodent brain [16], it remains obscure what cell-types
express atrn protein within the brain, and what its physi-
ological function is in the nervous system. Several patho-
logical studies have suggested the possibility that atrn is
involved in axon-oligodendrocyte interactions or in both
the assembly of myelin sheaths and the maintenance of
neurons, but the developmental profile of brain oli-
godendrocytes of the zi/zi rat has not been characterized
extensively to date. Moreover, these previous studies have
raised the question of whether zi/zi hypomyelination is
caused primarily by a developmental failure of oli-
godendrocytes themselves, or alternatively, by secondary
consequences of an impairment of neuronal differentia-
tion; they also raise the question of why the incidence of
abnormalities in oligodendrocyes is so low (see above).
It has been suggested that atrn also has multiple functions
outside the nervous system, including roles in monocyte
responses, hair pigmentation, energy control and obesity
[17-19]. In the immune system, membrane-type atrn was
recently shown to possess dipeptidyl peptidase IV (DP
IV)/CD26-like ectoenzyme activity, and to be expressed
on the surfaces of human peripheral blood monocytes
[20], while the in vitro study provided compelling evi-
dence that secreted form of atrn in human plasma has no
DP IV activity [21]. CD26 is expressed on the surfaces of
hemopoietic stem/progenitor cells, and plays a crucial
role in their homing/mobilization ability to/from the
bone marrow, through the proteolytic cleavage of a local
pool of chemokine SDF-1α [22]. Although atrn exhibits
no structural similarity to CD26, it is now thought that
atrn is a member of a unique DP IV-family designated the
DASH (DP IV activity and/or structure homologues) fam-
ily based on the comparable substrate specificity of atrn to
DP IV [23]. Thus, it is intriguing to find a linkage between
the oligodendrocyte degeneration in the zi/zi CNS and the
tightly regulated expression of atrn in the immune system.
In the present study, we describe the developmental pro-
file of oligodendrocytes and the brain pathogenesis in the
zi/zi rat in detail. Our observations suggest the possibility
that the loss of function in atrn might cause the abnormal
infiltration of macrophages/microglia into the brain,
mediating the oligodendrocyte morbidity in zi/zi rats.BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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Results
Impaired development of oligodendrocytes in zi/zi 
mutants
We first addressed the developmental profile of oli-
godendrocytes in zi/zi rats at postnatal day 5, when the
initial myelination is progressing in the CNS, based upon
immunohistochemical staining using the antibody Rip,
an antigen specific to oligodendrocytes. Rip antibody rec-
ognizes the cytoplasm and processes of cells in an oli-
godendrocyte lineage from their early stages to late
differentiated stages; that is, non-myelinating (promyeli-
nating oligodendrocytes), pre-ensheathing immature oli-
godendrocytes and myelinating oligodendrocytes [24,25].
During the early postnatal development of the CNS, there
is a caudo-rostral gradient of increasing oligodendrocyte
differentiation and myelination; Rip immunolabelling
emerges from the more caudal area to the more rostral
area in the CNS. To investigate whether the commence-
ment of myelination is impaired in zi/zi brain, coronal
sections through the hindbrain regions were immunos-
tained for Rip. In the developing gray matter regions in
the pons (vestibular nuclei), there were a large number of
promyelinating oligodendrocytes, which is the earliest
form of oligodendrocytes recognized by Rip (Fig. 1A,B).
These promyelinating oligodendrocytes have a character-
istic "starburst" morphology, prior to commencing
ensheathment (Fig. 1C,D), as described previously [25].
The number and morphology of promyelinating oli-
godendrocytes in the zi/zi brain appeared to be indistin-
guishable from those in control rats. At the same time, we
observed many Rip-positive myelinating oligodendro-
cytes extending multiple and linear process arrays
ensheathing longitudinal axon bundles within the devel-
oping reticular formation of the pons (Fig. 1E,F). Many of
these cells often had linear arrays connected to the cell
body by primary processes (Fig. 1E,F, arrows) and con-
tained both non-ensheathing processes and internodal
myelin sheaths, giving them an appearance of cells under-
going myelination. It has been proposed that these myeli-
nating oligodendrocytes subsequently go through a phase
of terminal differentiation until the immature internodal
myelin sheaths grow symmetrically, and definitive inter-
nodal lengths are established [25,26]. Our light micro-
scopic observations revealed that most myelinating
oligodendrocytes in zi/zi brain show no significant differ-
ence in terms of morphology compared with control ani-
mals (Fig. 1G,H). These observations indicated that the
onset of oligodendrocyte myelination is not adversely
affected in the zi/zi CNS.
We next analyzed the oligodendrocytes in zi/zi rats at 4
weeks of age, when the initial phase of myelination had
probably just been completed in the forebrain, based
upon immunohistochemical staining using antibodies
against Rip and neurofilament (NF), a marker for axons.
The cerebral cortices of heterozygous control rats (zi/+)
showed numerous Rip-positive oligodendrocytes
throughout the cortex (Fig. 2A). Many Rip-positive oli-
godendrocytes could be found in the molecular layer of
the gray matter and in the white matter of the cerebral cor-
tex. Individual Rip-positive cells had small, round-to-oval
cell bodies with characteristic tubular processes branching
longitudinally, parallel to the axons, typical of differenti-
ated myelinating oligodendrocytes (Fig. 2A,E). By con-
trast, the zi/zi cortex had a markedly reduced number of
Rip-positive cells. In particular, the generation and differ-
entiation of oligodendrocytes was drastically perturbed in
the superficial layer, including the molecular layer (layer
I) (Fig. 2B). Rip-positive cells that were sparsely distrib-
uted in the deeper layers (layers II-VI) of the zi/zi rat exhib-
ited severe morphological abnormalities, including
distorted cell bodies with fine and wavy processes that
branched irregularly (Fig. 2B', F, G). On the other hand,
axonal development appeared to be normal in zi/zi rats.
The axonal extension and density of NF-positive descend-
ing and ascending fibers in layers II-V of the zi/zi rat were
comparable to those in the control rat cortex (Fig. 2C,D).
Similar developmental defects of oligodendrocytes were
observed in the basal ganglia and cerebellum. In the cau-
date-putamen of the zi/zi rat, Rip-positive oligodendro-
cytes showed an abnormal morphology of thinner and
arborized processes, frequently accompanied by a large
number of spherical or granule-like fragments, which
were immunoreactive for Rip (Fig. 2I). The extension of
NF-positive axons and the appearance of axon bundles in
zi/zi rats were similar to those in control rats (Fig. 2K). In
the control cerebellum, many differentiating Rip-positive
oligodendrocytes appeared within the deeper aspects, the
granule cell layer and the putative white matter tracts by
postnatal 4 weeks, as myelination progressed. These oli-
godendrocytes and their tubular processes were aligned
radially, coursing from the white matter tracts through the
Purkinje cell layer to the molecular layer (Fig. 3A, A').
Such a well-organized arrangement of processes could not
be found in the zi/zi mutant cerebellum (Fig. 3B). Almost
all cerebellar oligodendrocytes of zi/zi mutants had irreg-
ularly aligned short processes in the granule cell layer (Fig.
3B'), suggesting perturbed differentiation of zi/zi cerebel-
lar oligodendrocytes. It was also noticed that there were
few differentiating oligodendrocytes within the molecular
and Purkinje cell layers in the zi/zi cerebellum, in contrast
to the appreciable number of Rip-positive processes in the
corresponding areas of the control rat (Fig. 3A). We failed
to find any differences in the distribution profiles of cere-
bellar axons between zi/zi and zi/+ rats, at least by postna-
tal 4 weeks (Fig. 3C,D), as was also the case in the
forebrain. In zi/zi rats, NF-expressing fibers radially cours-
ing through the granule cell layer, including afferent
climbing, mossy fibers and the efferent fibers from
Purkinje cells, appeared normal in number and density.BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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Myelination in the zi/zi hindbrain Figure 1
Myelination in the zi/zi hindbrain. Coronal sections of the pons from zi/zi (B, D, F, H) or control SD (A, C, E, G) rats at P5 were immunostained with antibodies for Rip. A, 
B, Medial vestibular nuclei, the developing grey matter in the dorsal region of pons. A large number of Rip-positive promyelinating oligodendrocytes, which had a starburst mor-
phology (arrows), were observed in both the control (A) and zi/zi (B). C, D, High-power photomicrographs of each promyelinating oligodendrocytes, respectively. The zi/zi pro-
myelinating oligodendrocyte (D) exhibited an oval cell body with multiple filopodia and a profuse network of processes, similar to those of wild-type (C). E, F, Reticular 
formation of pons. There were many Rip-positive myelinating oligodendrocytes ensheathing longitudinal axon bundles. G, H, High-power photomicrographs of the myelinating 
oligodendrocyte in the control (G) or zi/zi (H). Each myelinating oligodendrocyte had the multiple linear processes arrays connected to the cell body by primary processes 
(arrows), indicating that they had commenced axonal ensheathment. Scale bars: 100 μm (A, B); 20 μm (C, D); 100 μm (E, F); 20 μm (G, H).BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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Developmental defect of oligodendrocytes in the zi/zi cerebrum Figure 2
Developmental defect of oligodendrocytes in the zi/zi cerebrum. Coronal sections of the cerebral cortex (A-G) and caudate-putamen (H-K) at 4 weeks of age were 
immunostained with antibodies for Rip (A, B, E-I) or neurofilament (C, D, J, K). The genotype (zi/zi or control zi/+) is indicated in each panel. A-D, Cerebral cortex showing 
Rip-positive oligodendrocytes (A, B) and neurofilament-positive axons (C, D). The pial surface is at the top. A'-D', High-power photomicrographs of individual processes of Rip-
positive oligodendrocytes (A', B') and neurofilament-positive axons (C', D') in the gray matter (layers II-III). In the zi/+ cortex, immunoreactive cells for Rip, which possessed rel-
atively thick and branched processes, were abundantly distributed in cortical layers II-VI, but were sparse in superficial molecular layer I. By contrast, Rip-positive cells in the zi/
zi cortex were significantly decreased in number throughout the cortex. E-G, High-power views of individual Rip-positive cell in layers I-II. Rip-positive cells in zi/+ rats represent 
the typical morphology of myelinating oligodendrocytes, with round cell bodies and branched processes aligned in parallel (E), whereas Rip-positive cells in zi/zi rats frequently 
showed a morphological abnormality of distorted-shaped cell-bodies with fine and wavy processes that branched irregularly (F, G). H-K, Caudate-putamen of the basal ganglia 
immunostained for Rip (H, I) and neurofilament (J, K). In the zi/zi rat, Rip-positive oligodendrocytes exhibited an abnormal morphology with thinner and arborized processes, 
frequently accompanied by many spherical or granule-like fragments (I). Extension of neurofilament-positive axons and axon bundles appeared normal in zi/zi rats (K). Scale bars: 
50 μm (A-D); 20 μm (A'-D', E-K).BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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Developmental defect of oligodendrocytes in the zi/zi cerebellum Figure 3
Developmental defect of oligodendrocytes in the zi/zi cerebellum. Sagittal sections of the cerebellum from zi/+ (A, A', 
C) or zi/zi (B, B', D) rats at 4 weeks of age were immunostained with antibodies for Rip (A-B') or neurofilament (C, D). A, B, 
Differentiating Rip-positive oligodendrocytes were distributed predominantly within the internal granule cell layer (gcl) and the 
white matter tracts in the zi/+ cerebellum (A), whereas Rip-positive processes of the zi/zi mutant cerebellum were distorted 
and irregularly arranged, and sparsely distributed within the gcl (B). A', B', Higher magnifications of the molecular layer (ml), 
Purkinje cell layer (pcl) and gcl shown in A and B, respectively. The cerebellar oligodendrocytes in zi/zi rats exhibited irregularly 
aligned short processes. C, D, The number, density and distribution pattern of neurofilament-positive axons in zi/zi cerebellar 
folia (D) were indistinguishable from those in the zi/+ cerebellar folia (C). Scale bars: 50 μm (A, B, C, D); 25 μm (A', B'). gcl, 
internal granule cell layer; ml, molecular layer; pcl, Purkinje cell layer.BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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Thus, the spatial distribution of Rip immunoreactivity
strongly supported the idea that the loss of function in
atrn primarily causes defects in oligodendrocyte differen-
tiation within wide areas of the brain, but does not affect
neuronal development per se, the process of axonal
sprouting or axonal projection. Given that the initial
phase of myelination is not severely perturbed in the cau-
dal regions of zi/zi CNS during the early postnatal period,
it is likely that the hypomyelination and aberrant myelin
sheath formation in zi/zi mutants result from a failure in
the terminal differentiation of incipient myelinating oli-
godendrocytes; that is, defects in the subsequent exten-
sion or maintenance of oligodendrocytic processes.
Alternatively, it is also possible that the hypomyelination
in zi/zi brain might be caused by a toxic effect on oli-
godendrocytes and myelin after its normal formation.
Iron accumulation in zi/zi oligodendrocytes in an age-
dependent manner
Next, we addressed whether these injured oligodendro-
cytes produce pathological conditions after brain devel-
opment in zi/zi rats. Previous studies have shown that iron
is enriched within oligodendrocytes and myelin under
normal physiological conditions [27]. The role that high
levels of iron perform within oligodendrocytes has not
been fully established, but this elevated iron content has
been suggested to promote pathogenesis during disease
states such as PD and MS, due to the ability of iron to cat-
alyze the formation of hydroxyl radicals that lead to oxi-
dative tissue damage (for example, lipid-peroxidation and
protein oxidation) [28]. Histological examinations have
revealed the abnormal accumulation of iron in oli-
godendrocytes in aged zi/zi rats. As shown in Figure 4, the
accumulation of iron was observed in axonal elements of
white matter tracts, as well as in oligodendrocytes. Prom-
inently affected areas included the substantia nigra (Fig.
4A–F), globus pallidus (not shown) and cerebellum (Fig.
4G–L). Iron accumulation was first observed as early as 4
postnatal weeks within the hindbrain regions of zi/zi rats,
including the cerebellar white matter (Fig. 4H,J). With
increasing age from 2 to 8 months, iron accumulation was
accelerated and observed in discrete regions of the zi/zi rat
white and gray matter. In the substantia nigra pars reticu-
lata, heavy deposition of iron was detected in the cyto-
plasms of a large number of oligodendrocytes (Fig.
4Finset), axon bundles in the vicinity of these cells (Fig.
4F), and peri-neuronal cells (Fig. 4M). In the cerebella at
8 month-old zi/zi rats, accumulation of iron was a promi-
nent feature in interfascicular oligodendrocytes (Fig.
4L,N). An electron microscopic study confirmed iron
deposits in the cytoplasm and myelin sheaths of oli-
godendrocytes surrounding axons (Fig. 4O,P).
To further evaluate the pathologic consequences of the
accumulation of excess iron, we compared the pattern of
iron staining with that of ferritin expression. Ferritin is a
heteropolymeric iron-storage protein composed of H and
L subunits that assemble to form a hollow sphere in
which ferric iron precipitates are sequestered. In the aged
zi/zi cerebellum, markedly increased ferritin H/L expres-
sion (Fig. 5D) was detected throughout the white matter,
and the soma and axons of Purkinje cells where iron accu-
mulated (Fig. 5B). Similar up-regulation of ferritin was
observed in small cells located within substantia nigra
(Fig. 5E,F). Many of these ferritin-positive cells were Rip-
positive oligodendrocytes, as revealed by double immu-
nostaining (Fig. 5G). Notably, scattered and diffused
immunoreactivity for ferritin was frequently observed
around Rip-positive oligodendrocytic processes, as if there
was a leakage of ferritin from these processes (Fig. 5H).
Absence of attractin expression from cells of an 
oligodendrocyte lineage
The distribution of atrn protein in the nervous system
remains unclear, as there has been no available anti-atrn
antibody with which to localize atrn in brain sections,
immunohistochemically. In order to examine the precise
localization of membrane-bound atrn protein in the CNS,
polyclonal antiserum (anti-atrn) was generated in rabbits
using a peptide corresponding to the carboxy-terminal 14
amino acids of rat atrn [29]. This antibody recognized an
approximately 160 kDa protein, membrane-bound type
atrn, but did not cross-react with secreted atrn. Immuno-
histochemical analysis revealed that atrn was widely, but
heterogeneously, distributed. Prominent expression of
atrn was found in a large number of neurons, including
pyramidal neurons in the neocortex (Fig. 6E) and granule
neurons in the cerebellum (Fig. 6H). In most neurons,
atrn protein was predominantly distributed in the soma
and proximal dendrites. Next, we examined whether atrn
is expressed in cells of an oligodendrocyte lineage in wild-
type brain. A2B5 antigen and platelet-derived growth fac-
tor receptor-α (PDGFRα) are markers of oligodendrocyte
progenitors (OPCs) and pro-oligodendrocytes, while
galactocerebroside (GC or O1 antigen) and 2', 3'-cyclic
nucleotide 3'-phosphodiesterase (CNPase) are used to
detect premyelinated and mature oligodendrocytes.
PDGFR-α-positive cells residing in the subventricular
zone (SVZ) through the first postnatal week have been
proposed to be the earliest form of oligodendrocyte pro-
genitor cells that divide in the SVZ to give rise to slightly
more differentiated cells of an oligodendrocyte lineage in
nascent parenchyma such as the corpus callosum and the
cortex [30]. At postnatal day 2 (P2) and 7 (P7), we could
not detect any immunoreactivity to anti-atrn within the
brain parenchyma, including germinal cells, which were
densely packed within the SVZ (Fig. 6A–D).
Double-labeling experiments demonstrated that atrn was
not expressed by PDGFR-α- or A2B5-positive cells (Fig.BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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Iron accumulation in zi/zi rat oligodendrocytes Figure 4
Iron accumulation in zi/zi rat oligodendrocytes. Accumulating iron was stained using the enhanced Perls' method.A-D, 
Coronal sections of midbrain. Iron was present within the entire midbrain region in zi/zi rats (B). With increasing age (8 
months), iron accumulation became prominent in the substantia nigra (D). E, F, Higher magnifications of the substantia nigra 
region shown in C and D, respectively. In zi/zi rats, iron was present in axon bundles and in oligodendrocytic cell bodies and 
processes (F,inset). G-L, Iron staining of coronal sections of the cerebellum, counterstained with methyl-green. Iron accumula-
tion was initially detected in the cerebellar white matter at 4 weeks (4w) of age (G, H). I, J, Higher magnifications of the white 
matter, shown in the rectangular areas in G and H, respectively. K, L, Iron deposition increased with age (8 months) within the 
cerebellar white matter areas in zi/zi rats. M, High-power view of iron-containing cells in the zi/zi substantia nigra. Arrow indi-
cates an iron-accumulating cell that had the morphology of a small and oval cell body with a few short processes, representing 
an oligodendrocyte. n represents a large neuronal cell stained with cresyl-violet. N, High power view of the zi/zi cerebellar 
white matter, showing the cytosolic accumulation of iron (brown) in the interfascicular oligodendrocytes. O, P, Electron micro-
scopic photomicrographs of Perls' DAB iron staining of the aged zi/zi substantia nigra (8 months), showing iron deposits in 
cytoplasm of oligodendrocytes (O, arrows). The processes of these iron-laden oligodendrocytes frequently encompassed the 
axon (P, asterisk). Scale bars: 1 mm (A-D); 100 μm (E, F, I, J); 500 μm (G, H, K, L); 5 μm (M, N); 1 μm (O); 200 nm (P).BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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6A–D), confirming the absence of atrn protein in OPCs at
the early postnatal stage. During the process of cellular
differentiation, atrn protein is likely to be missing in cells
of an oligodendrocyte lineage. Consequently, atrn was
found to be absent from almost all differentiated oli-
godendrocytes in the mature brain (Fig. 6F–H). Double
immunofluorescence staining revealed non-overlapping
expression of atrn and CNPase. Virtually all CNPase-posi-
tive oligodendrocytes in the neocortex (Fig. 6G), striatum
(data not shown) and the granule cell layer of cerebellum
(Fig. 6H) were devoid of staining for atrn. However, it
should be noted that there was a small population of oli-
godendrocytes that were positive for atrn in the adult
brain. For example, atrn was expressed in approximately
only 2–5% of the oligodendrocytes within the corpus cal-
losum. The vast majority of these cells, which formed clus-
ters in rows, have small and oval cell bodies and
resembled typical myelinating oligodendrocytes, were
immunonegative for anti-atrn (Fig. 6F). The specificity of
the anti-atrn antibody we used in this report was validated
by immunohistochemical analysis using wild-type and zi/
zi mutant brains. Since we could not find any anti-atrn
immunoreactivity in zi/zi mutant brain sections (Fig. 6I,J
and ref. [29]), the possibility that the cellular heterogene-
ity of oligodendrocytes (positive or negative for atrn)
might result from a staining artifact could be excluded.
Up-regulation of ferritin in oligodendrocytes in zi/zi rats Figure 5
Up-regulation of ferritin in oligodendrocytes in zi/zi rats. A-D, Iron staining (A, B) or immunostaining of ferritin (C, D) 
in the cerebella of 8-month-old zi/zi (B, D) and age-matched zi/+ rats (A, C). E, F, Immunostaining of ferritin in the substantia 
nigra of 8-month-old zi/zi and zi/+ rats. Insets show ferritin-positive cells in the substantia nigra reticulata. G-H', Confocal 
images of double labeling for Rip and ferritin in the zi/zi substantia nigra, showing the increased expression of ferritin in Rip-
positive oligodendrocytes (arrows). The diffuse immunoreactivity of ferritin was often observed around the Rip-positive oli-
godendrocytic processes (asterisk). Panels G/G' and H/H' represent pairs of double stained photomicrographs. Scale bars: 10 
μm (A-D); 500 μm (E, F); 10 μm (insets in E, F); 10 μm (G-H'). wm, cerebellar white matter.BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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These observations suggest the possibility that atrn does
not exert an intrinsic function in most oligodendrocytes
residing in the postnatal brain. The detailed characteriza-
tion of the anti-atrn antibody, together with an analysis of
the spatio-temporal expression pattern and subcellular
distribution of atrn, has been described in our resent
report [29].
Normal development of zi/zi oligodendrocytes in vitro
To examine whether the numbers and distribution of glial
progenitors, including OPCs, were distorted in zi/zi rats in
vivo, we examined Olig2 expression in the SVZ in the early
postnatal forebrain (P7). The basic helix-loop-helix tran-
scription factor Olig2 is specifically expressed in gliogenic
progenitors in the early postnatal SVZ [31]. In the zi/zi
forebrain at P7, Olig2-positive cells were widely dispersed
in the SVZ region of the lateral ventricle in addition to the
subcortical white matter and developing striatum (Fig. 7).
The distribution pattern and number of glial progenitors
within the zi/zi SVZ expressing Olig2 were indistinguisha-
ble from those of the control rat (Fig. 7A,B). This observa-
tion allowed us to rule out the possibility that a decreased
number of glial progenitors, including OPCs, in zi/zi brain
contributes to the developmental defects in the oli-
godendrocyte lineage.
Considering the lack of atrn in cells of an oligodendrocyte
lineage, and the normal distribution of Olig2-positive
OPCs in the zi/zi SVZ, we upheld a hypothesis that the
impaired developmental failure of zi/zi oligodendrocytes
might be caused by a non-cell autonomous mechanism;
that is, that some external factor(s) that was increased or
decreased in concentration outside the oligodendrocytes
in  zi/zi  rats detrimentally influences oligodendrocyte
development. To assess this possibility, we next examined
the developmental potential and the ability for terminal
differentiation of zi/zi oligodendrocytes in vitro, using a
primary culture of purified OPCs. Purified OPCs were cul-
tured from neonatal zi/zi  brains in serum-free defined
medium containing the mitogens PDGF and bFGF; there-
after, these progenitors were induced to differentiate into
mature oligodendrocytes. Cultures were used for study
only if astrocytes comprised <1% and microglia <0.5% of
the total cell number, thus eliminating the effect of other
glial cell types. Cultures were characterized immunocyto-
chemically using antibodies against the surface antigens
A2B5 and galactocerebroside GalC, sequential expression
of which defines early progenitors (OPC) and terminally
differentiated oligodendrocytes, respectively, as described
previously [32]. As shown in Fig. 7, A2B5-positive OPCs
prepared from zi/zi  rats displayed a typical bipolar or
poorly branched morphology (Fig. 7C,E), and could pro-
liferate normally in the presence of mitogens, similar to
OPCs from wild-type SD rats (Fig. 7D) (percentage of cells
that were A2B5 positive: zi/zi rats, 81 ± 6.1% vs SD rats, 73
Absence of atrn protein in oligodendrocyte lineage Figure 6
Absence of atrn protein in oligodendrocyte lineage. Characterization of atrn-
expressing cells in the early postnatal forebrain at P2 (A, B), P7 (C, D), and in the 2-
months-old adult brain (E-H). A, B, Confocal images of double immunofluorescence 
labeling of the subventricular zone (SVZ) surrounding the dorso-lateral corner of the 
lateral ventricle of wild-type rats, using antibodies against PDGFR-α (red) and atrn 
(green). Atrn expression was not detected in PDGFR-α-positive cells (arrows). C, D, 
Confocal images of the wild-type SVZ immunostained for A2B5 (red) and atrn (green). 
Cell nuclei were visualized by TOPRO-3 staining (blue). Insets show an enlarged view 
of the SVZ. Arrowhead depicts A2B5-positive but atrn-negative OPCs among the 
densely packed cells in the SVZ. E, Atrn-positive cells (DAB, brown) in the gray mat-
ter (layer V) of the adult cerebral neocortex. Atrn expression was observed in neu-
rons including typical pyramidal neurons. F, Atrn-positive cell (DAB, brown) in the 
corpus callosum of the adult forebrain was indicated by arrow. G, H, Confocal 
images of double immunofluorescent labeling with antibodies to atrn (green) and 
CNPase (red) in the adult cerebral cortex (layers II-III) (G) or the internal granule cell 
layer of the adult cerebellum (H), respectively. Atrn expression was observed in 
many pyramidal or granule neurons, but not in CNPase-positive oligodendrocytes 
(arrows). I, J, Immunohistochemical analysis for specificity of anti-atrn antibody in rat 
brain. Coronal sections through the adult cerebral cortex were immunostained with 
anti-atrn antibody. Atrn-immunoreactivity in wild-type SD (I) and zi/zi (J) rats. Scale 
bars: 20 μm (A, B); 100 μm (C, D); 10 μm (E, F); 10 μm (F); 20 μm (G); 100 μm (I, J). 
lv, lateral ventricle.BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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In vitro differentiation assays of oligodendrocytes and semiquantitative analysis of cytokine/chemokine mRNAs Figure 7
In vitro differentiation assays of oligodendrocytes and semiquantitative analysis of cytokine/chemokine mRNAs. A, B, Distribution of Olig2-positive glial progen-
itors (brown) in the SVZ surrounding the lateral ventricle in the wild-type (SD) rat (A) or zi/zi rats (B) at P7. Lateral is to the right and dorsal is up. Insets indicate higher magnifi-
cations of Olig2-positive cells lying in the SVZ. C-I, Primary culture of OPCs and subsequent in vitro differentiation assays. C, D, OPCs from zi/zi (C) or control wild-type rat 
brains (D) were immunostained with A2B5 (green). Nuclei were counterstained with Hoechst dye (blue). E, Higher magnification of A2B5-positive OPCs prepared from zi/zi 
pups, representing a bipolar morphology. F, A differentiated culture of oligodendrocytes from zi/zi rats was immunostained with GalC (green). G, H, Higher magnification of 
GalC-positive cells induced from zi/zi OPCs (G) or control OPCs (H). I, Quantification of the fractions of A2B5-positive OPCs and GalC-positive differentiated oligodendro-
cytes. The ratios of the number of cells positive for each marker to the total number of cells were calculated and presented as the mean ± SEM (%). Scale bars: 100 μm (A, B); 
20 μm (inset in A); 50 μm (C-E); 20 μm (F-H). J, Semi-quantitative RT-PCR analysis of cytokine, chemokine and CD26 mRNAs. Total RNA samples prepared from whole brains 
of zi/+ or zi/zi rats, at P5 or P30, were subjected to RT-PCR analysis using the primer pairs indicated at the right side of the panels. RT-PCR for gapdh mRNA was used as an 
internal control. A typical electrophoresis pattern of the RT-PCR products is shown on an agarose gel. K, The mRNA levels in P5 brains were expressed as relative fold change 
(RFC) ± SEM. unpaired t-test: **, P < 0.05; *, P < 0.01; compared with control zi/+ rats.BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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± 8.6%) (Fig. 7I). In a differentiated culture, there was no
difference in the frequency of OPCs differentiating into
GalC-positive cells between zi/zi and wild-type rats (per-
centage of cells that were GalC positive: zi/zi rats, 26 ±
3.4% vs SD rats, 32 ± 5.2%) (Fig. 7I). GalC-positive oli-
godendrocytes developed from zi/zi  OPCs exhibited a
morphologically mature cell shape and a profuse network
of processes and membranes, similar to oligodendrocytes
from wild-type rats (Fig. 7F–H). The number of astrocytes
or microglia did not increase with differentiation of the
cultures (data not shown). These results indicated that
cells of an oligodendrocyte lineage from zi/zi rats possess
normal potential for proliferation and differentiation, at
least in vitro, and supported the idea that the abnormal
development of oligodendrocytes in zi/zi  rats is not
caused by a failure of the intrinsic program in oli-
godendrocytes themselves, but rather, by changes in
extrinsic factors that can influence oligodendrocyte devel-
opment.
Changes in the expression of proinflammatory cytokines/
chemokines in zi/zi brains
One group of candidate extrinsic factors that affect oli-
godendrocyte development is the proinflammatory
cytokines and chemokines. Some proinflammatory
cytokines or chemokines, oversupplied from other CNS or
non-CNS regions, may exert their toxic effects directly on
oligodendrocytes in zi/zi rats from an early developmental
stage. To determine the levels of various cytokines in zi/zi
brains, semi-quantitative RT-PCR was performed for inter-
leukin-1β (IL-1β), interleukin-6 (IL-6), interferon-γ (INF-
γ), tumor growth factor β (TGF-β) and tumor necrosis fac-
tor-α (TNF-α) at postnatal day 5 (P5) and day30 (P30).
We also determined the levels of several CC chemokine
mRNAs, including those for MCP-1 (CCL2), MIP-1α
(CCL3) and RANTES (CCL5), as well as the levels of the
CXC chemokine mRNAs for GRO-1 (CXCL1), MIP-2
(CXCL2) and SDF-1α (CXCL12a), and the two chemok-
ine receptors, CXCR3 and CXCR4. As shown in Figure 7J
and 7K, IL-1β mRNA expression was significantly higher
(2–4 fold) in zi/zi brains than in control brains, even at P5
(zi/+ vs. zi/zi; 0.392 ± 0.217 vs. 1.575 ± 0.321* at P5, and
0.709 ± 0.212 vs. 1.447 ± 0.315* at P30, values are repre-
sented as means ± SEM of the relative expression ratio to
the level of GAPDH, P* < 0.01 unpaired t-test). Such ele-
vated expression of IL-1β mRNA was observed at least up
to 5 months of age (data not shown). The levels of TGF-β,
TNF-α and INF-γ (data not shown) mRNAs were
unchanged between zi/zi and control brains. Expression of
IL-6 mRNA was undetectable in both groups. Interest-
ingly, gene expression profiling studies of the cerebral cor-
tex and striatum from zi/zi  rats, using the Affymetrix
Microarray system, indicated a significant up-regulation
of IL-1β converting enzyme (ICE) mRNA (data not
shown). Among the chemokines we examined, MIP-1α
(macrophage inflammatory peptide-1α) mRNA expres-
sion was detected at higher levels in zi/zi rats at P5 (×1.71
± 0.128, relative fold change compared with control zi/+
rats). We could not detect significant changes in the
mRNAs for any other chemokines in zi/zi rats.
On the other hand, we unexpectedly discovered a marked
upregulation of the mRNA for dipeptidyl peptidase IV
(DP IV/CD26) in zi/zi rats. The CD26 mRNA level was
upregulated approximately 2–3 fold in zi/zi  postnatal
brains (P5 and P30), compared with zi/+ brains (Fig. 7K).
CD26, a 110 kDa cell surface glycoprotein with a large
extracellular domain, a transmembrane segment and a
cytoplasmic tail, plays an important role in T cell co-stim-
ulation [33].
Prolonged activation and accelerated recruitment of 
macrophages/microglia in the zi/zi CNS
MIP-1α is known to be a potent chemoattractant for
monocytes and T-cells [34], and the increased expression
of several chemokines and cytokines, including MIP-1α
and IL-1β has been implicated in the immune cell mobi-
lization seen at the site of CNS injury [35]. In addition, it
has been shown that CD26 enhances chemotaxis and
transendothelial migration of T cells and monocytes
toward CC chemokines [36]. These findings assured us
that elevated levels of these mRNAs might be closely asso-
ciated with an infiltration of immune cells, such as mono-
cytes/macrophages, into the zi/zi brain parenchyma. To
test this possibility, we examined the dynamics of
immune cell populations during the early postnatal
stages, prior to the apparent onset of oligodendrocyte
defects in the zi/zi CNS. The mouse monoclonal antibody
OX-6, which recognizes MHC class II antigen, was used to
label antigen-presenting cells such as B-lymphocytes, den-
dritic cells and some macrophages [37]. ED1 antibody
recognizes CD68 [38], a phagocytic lysosomal membrane
antigen, and is a marker for monocytes, tissue macro-
phages and activated microglial cells, but not for ramified
microglial cells (resting microglia). Although we failed to
detect any alteration in the distribution of OX-6-positive
cells at P21 (data not shown), we observed a considerable
change in the spatio-temporal distribution of ED1-posi-
tive cells in zi/zi brain parenchyma. At P7, there were a
large number of ED1-positive macrophages distributed in
the  zi/zi  cerebellum (Fig. 8B) and forebrain, but the
number and distribution pattern of these cells appeared to
be indistinguishable from those in wild-type control sec-
tions (Fig. 8A). In the cerebellum, there was a dramatic
increase in the number of ED1-positive brain macro-
phages observed within the cerebellar fiber tracts, such as
the inferior cerebellar peduncle and folia white matter
(Fig. 8A,B). These cells were present from birth, with their
numbers increasing to a maximum at P7. By P14 in wild-
type rat brains, these ED1-positive cells become rapidlyBMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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Accelerated recruitment of macrophages/microglia into the brain parenchyma in zi/zi rats during early postnatal period Figure 8
Accelerated recruitment of macrophages/microglia into the brain parenchyma in zi/zi rats during early postna-
tal period. A-K, Distribution of ED1-positive cells in wild-type (A, C, E, G, I) and zi/zi (B, D, F, H, J-N) rats. A-D, Coronal 
sections of the developing cerebellum at P7 (A, B) and P14 (C, D). E, F, Higher magnification of the boxed regions in C and D, 
respectively, showing the ED1-positive cells in the internal granule cell layer of the paraflocculus. Arrow indicates a capillary. G, 
H, Choroid plexus in the lateral ventricles at P14. I, J, Coronal sections through the aqueduct of the P14 brain. Arrow indicates 
the abnormal accumulation of ED1-positive cells underneath the ependymal layer and the formation of polyp-like protrusions 
into the aqueductal lumen. K, Higher magnification of ED1-positive cells in the abnormal protrusion shown in J. L, Scanning 
confocal image of a transverse section of a blood vessel in the zi/zi pons at P21, representing the ED1-positive cells (green) and 
vWF-positive endothelial cells (red), with nuclear staining by TOPRO3 dye (blue). Asterisk indicates the vascular lumen. M, M', 
Confocal images of immunofluorescence labeling with ED1 (green) and Iba1 (red) across the vasculature in the P21 zi/zi cerebel-
lum. Arrows represent ED1-positive and Iba1-positive elongated cells found in the perivascular region. N, N', Confocal images 
of immunostaining for ED1 (green) and Iba1 (red) through the section of the internal granular cell layer of the P21 zi/zi cerebel-
lum. Arrows indicate the ED1-positive and Iba1-positive ramified microglia. Panels M/M' and N/N' represent pairs of double-
stained photomicrographs. Scale bars: 200 μm (A-D); 50 μm (E-H); 100 μm (I, J); 25 μm (K); 20 μm (L); 20 μm (M, N). ChP, 
choroid plexus; aq, cerebral aqueduct.BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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decreased in number (Fig. 8C), and thereafter, almost dis-
appeared from parenchyma by the third postnatal week.
Such dynamic temporal changes in the distribution pat-
tern of ED1-positive cells appeared to be consistent with
the normal distribution of rat brain macrophages
described by a previous study [39]. By contrast, it was evi-
dent that there was a persistent and prolonged accumula-
tion of large numbers of ED1-positive cells at discrete
regions in the zi/zi CNS, with most exhibiting a microglia-
like morphology (Fig. 8F,H). At P14, when evident oli-
godendroglial abnormalities still had not appeared in the
zi/zi  pups, at least at the light microscopic level, large
numbers of ED1-positive cells were already present in the
zi/zi CNS, in several fiber tracts including the longitudinal
fasciculus in the pons, the spinal trigeminal tracts, the
pyramidal tracts in the medulla, and the cerebellar pedun-
cles, in addition to structures outside the blood-brain bar-
rier, including the leptomeninges, choroid plexus and
circumventricular organs. Considerable accumulation of
ED1-positive cells in these areas was observed, at least
beyond the fourth postnatal week in zi/zi rats. This distri-
bution pattern of ED1-positive cells appeared to correlate
well with the brain areas where many oligodendrocytes
show obvious morphological changes. For instance, the
development of oligodendrocytes was severely perturbed
in the superficial white matter (layer I) of the zi/zi cerebral
cortex, as shown in Fig. 2. Consistently, we often observed
an increased number of ED1-positive cells within layer I,
in addition to the leptomeninge located adjacent to layer
I (data not shown). However, we failed to demonstrate
definitively a direct intercellular association between
ED1-positive cells and degenerated oligodendrocytes in
zi/zi cortex in situ, because of the high migrating ability of
these invading ED1-positive cells. In the zi/zi cerebellar
cortex at P14, there were also many scattered EDl-positive
cells found widely within the internal granule cell layer, in
addition to the folia white matter areas. These cells exhib-
ited an elongated or stellate morphology, extending sev-
eral ramified cytoplasmic processes, and were often
present adjacent to blood vessels (arrow in Fig. 8F). At this
time, a much lower number of EDl-positive cells could be
seen in the cerebellar cortices of control animals (Fig. 8E).
The number of ED1-positive cells located in the P14 zi/zi
cerebellar cortex (paraflocculus) was approximately 12-
fold higher than that in controls (control vs. zi/zi; 28 ± 13
vs. 358 ± 34*, values are represented as means ± SEM of
the number of ED1-positive cells/paraflocculus, P* < 0.01
unpaired  t-test), while no significant differences were
detected between the zi/zi and control cerebellar cortices
at P7 (control vs. zi/zi; 411 ± 57 vs. 483 ± 76). Again, such
accumulation of ED1-positive cells in the zi/zi cerebellum
coincided with the region where oligodendrocyte defects
and iron deposition preferentially take place; that is, a
large number of ED1-positive cells spread within the
internal granule cell layer and the deep white matter tract
of zi/zi cerebellar folia at P14, prior to the appearance of
gross abnormalities of oligodendrocytes (compare Fig. 3B
with Fig. 8F) and iron deposition (compare Fig. 4H,J with
Fig. 8D,F) in these regions. We also observed many ED1-
positive cells in the choroid plexus and in the periven-
tricular regions surrounding the ventricular system in the
zi/zi  CNS. EDl-positive cells in the choroid plexus had
large and round cell bodies with few or no cytoplasmic
processes (Fig. 8H), giving them an appearance of mono-
cytes/macrophages infiltrating into the cerebrospinal
fluid (CSF) from the periphery. In the periventricular
regions, it should be noted that large numbers of EDl-pos-
itive cells were apposed to and within the ependymal cell
layers that surround the cerebral aqueduct at P14 (Fig. 8J).
These EDl-positive cells frequently accumulated to form
clusters underneath the ependyma, so that distorted large
protrusions were invaginated into the aqueductal lumen
(Fig. 8J). Individual cells within clusters varied in mor-
phology from those with round cell bodies without proc-
esses to those with elongated cell bodies with relatively
thick and branched processes (Fig. 8K). Several EDl-posi-
tive cells were located within the ependymal cell layers, as
if they had just migrated out of the CSF (Fig. 8K). On the
other hand, in control rats, EDl-immunoreactive cells
were observed surrounding the aqueduct at birth, after
which they gradually decreased in number to become
almost undetectable by P12, with few ED1-positive cells
being detected thereafter (Fig. 8I).
We next attempted to determine the phenotype of EDl-
positive cells found in the zi/zi  parenchyma. Sections
across the pons and cerebellum at P21 were processed for
immunofluorescence detection with multiple cell type-
specific markers, counterstained with the nuclear dye
TOPRO3, and analyzed by confocal microscopy. An anti-
body to von Willebrand Factor (vWF) was used to label
the endothelial cells of blood vessels [40], and Iba1 (ion-
ized calcium-binding adapter molecule 1), a calcium
binding protein, was used to label resident microglia,
including both resting and activated forms [41,42]. As
shown in Fig. 8F, a significant number of EDl-positive
cells were intimately associated with the vasculature,
including capillaries and vessels of larger caliber, through-
out the brain. These cells exhibited an amoeboid or elon-
gated morphology, and contained an extensive
perinuclear cytoplasm, with few extending projections
(Fig. 8L,M). Combined immunostaining with vWF con-
firmed that these EDl-positive cells resided on the paren-
chymal side of the endothelium, but never within the
lumen (Fig. 8L). Anatomical distribution of these cells
suggested that they belong to a subset of macrophages
termed perivascular cells, which are not integral compo-
nents of the vascular wall and are derived from the bone
marrow, migrating into the brain parenchyma during
postnatal and adult life [43]. Of interest is the observationBMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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that almost all ED1-positive perivascular cells were also
immunoreactive for the microglial marker Iba1 (Fig. 8M).
On the other hand, there were a large number of ED1-pos-
itive stellate cells with thick ramified processes in discrete
regions of zi/zi brain, as shown in Fig. 8F. They were often
deeply implanted in the parenchyma, exhibiting no
apparent association with vascular elements. Double
immunostaining of sections through the zi/zi cerebellar
gray matter at P21 revealed that these cells were a subpop-
ulation of Iba1-positive microglia (Fig. 8N arrows), pre-
sumably corresponding to the activated microglial cells
characterized, in part, by the ED1-expressing phagocytic
lysosomes.
Taken together, recruitment of monocytes/macrophages
into the brain parenchyma and the subsequent activation
of microglia appeared to be accelerated in the zi/zi CNS
during the postnatal stage, prior to the appearance of their
abnormal clinical signs for hypomyelination.
Discussion
Non-cell autonomous impairment of oligodendrocyte 
differentiation in the zi/zi CNS
The present study provides a comprehensive phenotypic
profile of the zi/zi brain during the early postnatal period.
We observed the normal projection of neuronal axons
and the developmental failure of oligodendrocyte proc-
esses in zi/zi  rats. Onset of the impairment of oli-
godendrocyte differentiation might occur in a non-cell
autonomous manner in zi/zi rats. Aberrant extension of
cellular processes and hypomyelination of oligodendro-
cytes were not due to the failure of the intrinsic program
of oligodendrocytes, but rather, were caused by extrinsic
factors that interrupt oligodendrocyte development,
based on the facts that zi/zi OPCs exhibit normal compe-
tence for proliferation and differentiation into mature oli-
godendrocytes in an in vitro culture system. The
immunohistochemical evidence showing the absence of
atrn expression from the early stage of an oligodendrocyte
lineage reinforced the idea of non-cell autonomous fail-
ure of oligodendrocyte development in zi/zi rats. Such a
non-cell autonomous defect of oligodendrocyte develop-
ment may explain why the penetrance of abnormalities in
oligodendrocyes is low (see Background section). If zi/zi oli-
godendrocytes developed under the control of an
impaired intrinsic program, most of these cells should
exhibit a common and synchronous abnormality. Never-
theless it should be noted that there was a small popula-
tion of oligodendrocytes that were positive for atrn in the
adult brain [this study, and ref. [29]]. Thus, it is also pos-
sible that atrn bears a critical function in some oli-
godendrocytes. Loss-of-function of atrn in this small
population might be sufficient to initiate vacuolation in
the  zi/zi  rat. Alternatively, atrn may be transiently
expressed in most oligodendrocytes at the time when its
function is required. We might have failed to detect atrn
expression in oligodendrocytes due to the rapid down-
regulation of atrn in this cell lineage. A recent study dem-
onstrated that there is a decline in the amount of plasma
membrane lipid rafts in the liver and spleen cells prepared
from atrn mutant mice, suggesting a cell-autonomous
defect in the plasma membrane maintenance of atrn-defi-
cient cells [44]. Therefore, we cannot exclude the possibil-
ity that atrn transiently plays an intrinsic role in the
maintenance/integrity of the plasma membrane or the
myelin sheaths of oligodendrocytes. Another explanation
for the low penetrance of myelin defects observed in zi/zi
rat is the redundancy of the biochemical pathways in oli-
godendrocyes in which atrn functions. Atrn and atrnl1
(attractin like-1) gene products were shown to share sig-
nificant sequence similarity [45]. A genetic study using
transgenic and knock-out mice actually demonstrated that
over-expression of atrnl1 compensates for the loss of atrn
[45]. Given the similar patterns of expression of the two
genes in the adult rodent CNS [45], endogenous atrnl1
might partially compensate to prevent development of a
severe phenotype in the zi/zi CNS.
We should further note the possibility of inappropriate
expression of the secreted form of atrn in the zi/zi brain. In
the rat brain, the atrn gene is transcribed into two different
mRNAs with sizes of 9.0 kb and 4.5 kb, by alternative
splicing. The 9.0-kb transcript was deduced to encode
membrane-type atrn, while the 4.5-kb transcript was
deduced to encode the secreted type of atrn corresponding
to the secreted form of the human ATRN locus product
[13,46]. Our current and recent studies have shown the
absence of membrane-type atrn protein in zi/zi  brain
using an antibody specific for the cytoplasmic tail of
membrane-type atrn [this study and ref. [29]]; however, it
remains to be determined whether an abnormal secreted
form of atrn protein is generated in zi/zi brain. However,
we could exclude the possibility that the defect in zi/zi oli-
godendrocytes is due to the inappropriate expression of
the secreted form of atrn in the zi/zi rat brain for the fol-
lowing three reasons. (i) The deletion in the atrnzi allele
has been identified at the splice donor site of the intron of
the atrn gene, which is expected to result in unstable tran-
scripts. Certainly, previous Northern analysis showed a
marked decrease in both secreted-type and membrane-
type atrn mRNAs in the zi/zi brain [13]. Kuramoto et. al.
also mentioned the existence of faint and long multiple
atrn-related transcripts in zi/zi brain, although it remains
unclear whether or not these transcripts encode a func-
tional protein [13]. (ii) Transgenic rescue experiments
showed that membrane-type atrn is responsible for the
neuropathological phenotype in zi/zi  rats, but that the
secreted-type atrn cannot complement this mutant phe-
notype [13]. This result indicated that the zi/zi brain phe-
notype is attributable solely to the loss of membrane-typeBMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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atrn, even though secreted-type atrn might be up-regu-
lated in zi/zi brain. (iii) The mv/mv (myelin vacuolation)
rat, a spontaneous mutant harboring a genomic deletion
including exon 1 of the atrn gene (atrnmv), showed no
detectable expression of both secreted- and membrane-
type atrn mRNA in the brain [46]. The mv/mv rat brain
exhibits neurological and neuropathological phenotypes
including hypomyelination and vacuolation, which are
quite similar to those found in zi/zi brain. This finding
strongly suggests that the hypomyelination phenotype
observed in atrn mutant rats is not directly linked to the
expression of the secreted form of atrn. Nevertheless, it
has been largely unknown whether the secreted form of
atrn might exert a specific function in the normal rat and
human CNS. Moreover, it is of interest to note that the
morphological defects found in the zi/zi oligodendrocyte
processes appears remarkably similar to the effects of
secreted-type human atrn upon dendrite development in
differentiating neurons in vitro with "wavy processes that
branched irregularly" [47]. In order to explore the func-
tion of the secreted form in the CNS, an immunostaining
study using an anti-atrn antibody recognizing the secreted
form is in ongoing in our laboratory.
Our observations raised the possibility that macrophage/
microglia activation in the developing zi/zi brain leads to
the disturbance of oligodendrocyte differentiation in dis-
crete regions of the brain. Primitive macrophages/mono-
cytes have been proposed to be the cells of origin of
microglia. These cells are thought to enter the developing
brain parenchyma from the bloodstream, the ventricular
spaces or the meninges, during both the prenatal and
postnatal periods [1,48]. Although the relationship
between circulating macrophages and microglial lineage
cells is largely undefined, it is possible that the increase in
the number of Iba1-positive perivascular cells in the zi/zi
parenchyma is due to an increase in the population of
monocytes/macrophages recruited from the vessels and
destined to become microglia. Since both brain macro-
phages and CNS resident microglia retain common prop-
erties, including phagocytic ability, and are possible
sources of ROS, proinflammatory cytokines and chemok-
ines, the increased number of monocytes/macrophages/
microglia could initially dominate the development of
oligodendrocytes within discrete regions of the axon tract
through the production of toxic molecules, such as ROS,
IL-1β and MIP-1α, leading to the commencement of
hypomyelination in the zi/zi CNS.
Peroxides, including hydrogen peroxide (H2O2), are one
of the main ROS leading to oxidative stress [49]. A previ-
ous biochemical study [5] has shown lowered catalase
activity and increased activity of d-amino acid oxidase (d-
AAO) in zi/zi medulla, pons and cerebellum at P10, before
the appearance of morphological vacuolation in the
brains of suckling zi/zi rats. D-AAO is known to produce
ROS such as superoxide anion (O2
￿-) and H2O2, while cat-
alase scavenges H2O2. These findings suggest the abnor-
mal metabolism of H2O2 and a subsequent increase in the
amount of ROS in zi/zi brain. Consistently, our previous
studies demonstrated an accumulation of ROS in the
nigrostriatal dopaminergic system leading to axonal
degeneration or neuronal cell death being frequently
observed in the substantia nigra of aged zi/zi rats [6,8].
Chronic administration of vitamin E (D, L-α-tocophe-
nol), an effective free radical scavenger in the brain,
resulted in a significant increase in the number of surviv-
ing dopamine neurons in zi/zi brain [6], supporting ele-
vated oxidative stress in zi/zi rat brain. Importantly, cells
of an oligodendrocyte lineage, especially OPCs, have been
shown to be exquisitely vulnerable to oxidative stress [50-
52]. Therefore, we assume that free radical injury to devel-
oping oligodendrocytes underlies, in part, the pathogene-
sis of zi/zi rats. Presumably, the elevated level of ROS,
which are released from accumulated macrophages/
microglia, may impede oligodendrocyte differentiation
from OPCs during the early postnatal stage, leading to
hypomyelination as well as neuronal injury at a later
stage.
Proinflammatory cytokines, the mediator molecules of
inflammation, such as IFN-γ, TNF-α and IL-1β, have been
shown to be derived from macrophages/microglia and
have been implicated in the pathogenesis of demyelinat-
ing diseases [53,54]. In vitro culture studies indicated that
the developing oligodendrocytes exhibit higher suscepti-
bility to cytokine-mediated cytotoxicity compared with
mature oligodendrocytes [52,55]. IL-1β is a pleiotropic
cytokine expressed during normal CNS development and
in inflammatory demyelinating diseases. OPCs and differ-
entiated oligodendrocytes are known to express IL-1
receptors, and IL-1β has been shown to block the prolifer-
ation of OPCs in vitro [56]. As shown here, expression of
IL-1β mRNA is elevated from an early stage. This excess
delivery of IL-1β may promote the premature differentia-
tion of OPCs in the zi/zi brain.
Possible functions of Atrn in CNS
It is thought that atrn is involved in the initial axon-oli-
godendrocyte interaction and the assembly process of the
myelin sheath, because of the existence of extracellular
functional domains, which are usually required for recep-
tor-ligand interactions [14,18]. In this context, however,
we cannot explain the possible cellular mechanism by
which atrn mediates the activation or invasion of macro-
phages/microglia in the CNS. It was recently shown that
membrane-type atrn possesses an activity of dipeptidyl
peptidase IV (DP IV)/CD26-like ectoenzyme, and is
expressed on the surface of human peripheral blood
monocytes [20], while the in vitro study by Friedrich et al.BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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provided compelling evidence that atrn protein purified
from human plasma has no DP IV activity, suggesting that
atrn acts as a receptor or adhesion protein rather than a
protease [21]. CD26 is an ectoenzyme DP IV (EC
3.4.14.5) that releases N-terminal dipeptides from pep-
tides with proline in the penultimate position, and is
known to be expressed as both a secreted form and a
membrane-bound form localized on the surfaces of T
cells, B cells and natural killer cells [33]. Several chemok-
ines, including RANTES and SDF-1α, have been identified
to be hydrolyzed by CD26 [57]. A recent study suggested
that CD26 expressed on the surface of hemopoietic stem/
progenitor cells plays a crucial role in their homing/mobi-
lization ability to/from the bone marrow, though the pro-
teolytic cleavage of a local pool of SDF-1α [22]. Although
atrn exhibits no structural similarity to CD26, it is now
thought that atrn is a member of a unique DP IV-family
based on the comparable substrate specificity of atrn to
DP IV [20,23]. Our present study indicated that the
expression of SDF-1α mRNA in the brain was unaltered in
zi/zi rats. However, even though atrn cleaves SDF-1α as a
target chemokine with the same specificity as CD26, we
could not detect such a truncated form of chemokines, as
no available technique can discriminate these from the
full-length forms. If CD26 serves similar or redundant
functions to the atrn gene in the CNS, upregulation of its
mRNA may reflect a functional compensation for the loss
of atrn expression in zi/zi rats. In this context, the DP IV-
activity of atrn may be crucial for the onset or progression
of CNS degeneration in zi/zi  rats. Interestingly, it was
shown that atrn potentially influences monocyte function
through its DP IV activity; inhibition of DP IV activity in
stimulated cultured monocytes caused significantly
enhanced release of cytokines [20]. Moreover, inhibition
of its activity decreased the adhesion of cultured mono-
cytes to the extracellular matrix [20]. It should also be
noted that the secreted form of atrn circulating in human
plasma functions in the immune response, mediating the
spreading of monocytes that become the focus for the
clustering of nonproliferating T lymphocytes [17,58].
Taken together, these findings suggest the possibility that
the monocyte/macrophage carrying a mutation of the atrn
gene may alter the homing/mobilization ability, directing
cells towards the chemokines in the brain, or may disreg-
ulate their own adhesion properties through the endothe-
lium, leading to extravasation of macrophages into the zi/
zi brain parenchyma. Alternatively, atrn might principally
function in promoting the transformation of monocytes
into resting microglia in the brain. The accumulation of
ED-1-positive monocytes in the zi/zi CNS observed in this
report might reflect the fact that ED-1-positive cells fail to
become resting microglia and remain active in zi/zi brain.
Thus, there are more ED-1-positive monocytes/macro-
phages in zi/zi rats that express cytokines and chemokines.
Considering the expression of atrn in almost all OX42-
positive microglia [29], the loss of atrn may alter the char-
acteristics of microglia themselves, leading to the contin-
uous and increased production of ROS or cytokines/
chemokines in zi/zi  microglia, and toxicity to oli-
godendrocytes/myelin as a consequence. Appropriate and
persistent expression of atrn in monocytes/macrophages
may be required for their proper transform into resting
microglia in the brain.
On the other hand, it is well known that the majority of
microglia are derived from bone marrow cells during
embryogenesis and the early postnatal period. Recent
bone-marrow transplantation studies have indicated that
there exists slow supplementation of microglia by marrow
cells under physiological conditions, even in adult life
[43]. Atrn may be involved in brain morphogenesis by
suppressing the excessive migration of monocytes into the
CNS, or by accelerating the transformation of brain
monocytes into resident microglia, but its molecular
mechanisms remain to be elucidated. Transplantation
studies of EGFP-tagged zi/zi macrophages/microglia into
the wild-type brain, and co-culture experiments of acti-
vated zi/zi macrophages/microglia with oligodendrocytes,
which are currently in progress in our laboratory, will une-
quivocally reveal the function of this protein.
Relevance to neurodegenerative diseases
Iron-mediated oxidative damage to axons may be an early
event that is common to several neurodegenerative dis-
eases, such as AD, PD, MSA and MS [3,28]. In the zi/zi
brain, iron-accumulation became evident in oligodendro-
cytes with increasing age. Although it is still a matter of
debate whether iron accumulation is a primary cause of
neurodegeneration or a secondary consequence, there
seems to be no doubt that iron-induced oxidative stress
contributes to the pathogenesis of neurodegenerative dis-
eases, including animal models [59]. In addition, several
lines of evidence also suggest an involvement of macro-
phages/microglia in these neurodegenerative diseases.
Pronounced recruitment and activation of macrophages/
microglia into the brain parenchyma have also been
implicated in mediating oligodendrocyte and myelin
damage, leading to demyelination in MS and its murine
model EAE (experimental autoimmune encephalomyeli-
tis) [60]. Recent studies suggest an involvement of CD26/
DP IV-activity in the pathogenesis of MS, including T-cell
activation, cytokine production and lymphocyte invasion
into CNS tissues, through the proteolytic processing of
target chemokines [22,33,61]. In vivo experiments using a
potent synthetic inhibitor of DP IV demonstrated that the
clinical signs of EAE could be diminished by DP IV inhi-
bition, both in a preventive and therapeutic fashion, sug-
gesting a crucial role of DP IV activity in the pathogenesis
of MS [61]. In view of the compatible DP IV-activity
between atrn and CD26, the zi/zi rat might be a usefulBMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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model for studying the functions of DP IV in pathogenesis
linking the immune system with nervous system. To date,
we have found no hereditary neurological disorders that
map onto the human atrn gene locus. It will be interesting
to determine whether the atrn gene is implicated in neu-
rological disorders as a novel modifier.
Conclusion
Our studies provide evidence that onset of the impair-
ment of oligodendrocyte differentiation occur in a non-
cell autonomous manner in zi/zi rats. Based on the lack of
atrn expression from the early stage of an oligodendrocyte
lineage, along with the normal competence of zi/zi OPCs
for proliferation and differentiation in vitro, it is highly
likely that the hypomyelination of zi/zi oligodendrocytes
is not due to the failure of the intrinsic program of oli-
godendrocytes, but rather, is caused by extrinsic factors
that interrupt oligodendrocyte development. An
enhanced recruitment and prolonged activation of ED-1-
positive monocytes/macrophages into the zi/zi  brain
parenchyma during the early postnatal stage, prior to the
onset of hypomyelination, suggests the possibility that
these activated macrophage/microglial lineage cells might
induce disturbances in oligodendrocyte differentiation via
the secretion of deleterious factors including IL-1β and
MIP-1α. Atrn might be involved in the activation of brain
macrophages/microglia by suppressing excessive migra-
tion of monocytes into the CNS, or by accelerating the
transformation of brain monocytes into resting microglia.
Methods
Animals
Homozygous zitter mutant (zi/zi) rats were maintained as
a congenic strain with the genetic background of Sprague-
Dawley rats (SD). As control animals, we used age-
matched SD rats purchased from Charles River Japan Inc.
(Japan), or zitter heterozygote (zi/+) littermates, which
were obtained by intercrossing each strain. Rats were han-
dled according to the Guidelines for the Care and Use of
Laboratory Animals, Dokkyo Medical University School
of Medicine.
Tissue processing
The day of birth was designated as P0. Animals were
lethally anaesthetized with sodium pentobarbital admin-
istered i. p. (10 mg/kg) and perfused transcardially with
phosphate buffered saline (PBS), followed by 4% parafor-
maldehyde (PFA) in 0.1 M phosphate-buffer, pH 7.4 for
immunohistochemistry or by 1% glutalaldehyde, 4% PFA
in PB for Perls'/DAB iron staining [62]. Brains and other
tissues were dissected, postfixed overnight at 4°C, and cry-
oprotected in 30% sucrose in PBS at 4°C. Tissue sections
for indirect double immunostaining were cut coronally at
a thickness of 12 μm using a cryostat, and affixed to 3-
aminopropyltriethoxysilane-coated glass slides (Matsu-
nami, Osaka, Japan). For immunostaining with a single
primary antibody or Perls'/DAB iron staining, serial free-
floating sections were cut at a 30-μm thickness, rinsed
with 0.1 M PBS, and stored at 4°C.
Immunohistochemistry and immunofluorescence
Immunolabeling with a single primary antibody was per-
formed using the avidin-biotin-peroxidase technique
(Vectastain ABC kit, Vector Laboratories, Burlingame,
CA), according to the manufacturer's instructions. Briefly,
free-floating sections were quenched for endogenous per-
oxidase activity by treating them with 0.3% H2O2 in PBS
for 30 min at room temperature, blocked for 1 h in 10%
normal goat serum, and 0.3% Triton X-100 in PBS, and
then incubated with a primary antibody diluted in the
same blocking solution overnight at 4°C. Sections were
placed in an appropriate biotinylated secondary antibody
diluted in blocking solution for 2 h followed by incuba-
tion with avidin-conjugated horseradish peroxidase
(HRP). Immunoreactivities were visualized using 0.25
mg/ml diaminobenzidine (DAB) and 0.03% H2O2. Each
step was followed by four washes in PBS containing 0.3%
of Triton X-100 (PBST). For immunostaining with Rip
antibody, the sections were quenched with 0.3% H2O2
after incubation with secondary antibody. Double indi-
rect immunostaining was performed on frozen sections
with the appropriate combination of primary antibodies.
After four washes with PBST, bound antibodies were visu-
alized by incubation with Alexa Fluor 488- or 568-conju-
gated secondary antibodies (used at a dilution of 1:1000;
Molecular Probes, Inc. Eugene, OR). Cells were counter-
stained with 10 μM Hoechst 33342 dye (Sigma-Aldrich,
St. Louis, MO) or TOPRO-3 (Molecular Probes) to iden-
tify nuclei. After being rinsed with PBST, the specimens
were examined under a fluorescence microscope
equipped with the appropriate epifluorescent filters. Opti-
cal sections were viewed using the FV500 scanning laser
confocal imaging system (Olympus, Tokyo, Japan).
Antibodies
The following antibodies were used in this study: anti-
attractin (affinity purified rabbit polyclonal [29]); anti- 2',
3'-cyclic nucleotide-3'-phosphohydrolase (CNPase)
(mouse monoclonal IgG1, Sigma-Aldrich) diluted 1:200;
A2B5 (mouse monoclonal IgM, Chemicon, Temecula,
CA), diluted 1:500; O4 (mouse monoclonal IgM, Roche
Diagnostics), diluted 1:20; GalC (mouse monoclonal IgG,
Sigma), diluted 1:200; anti-PDGFR alpha (rat mono-
clonal IgG [63]), diluted 1:500; anti-Ferritin H/L (rabbit
antiserum, Sigma), diluted 1:1,000; anti-oligodendrocyte-
specific protein, Rip (mouse monoclonal IgG1, Chemi-
con), diluted 1:10,000; anti-Neurofilament 70/200 kDa
(mouse monoclonal IgG1, MP Biomedicals, Costa Mesa,
CA), diluted 1:200; ED1 (mouse monoclonal IgG1,
Chemicon), diluted 1:1,000; anti-Iba1 (rabbit polyclonalBMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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antibody, Wako Pure Chemical Industries, Japan), diluted
1:2,000; MRC OX-6 (mouse monoclonal IgG1, Serotec,
UK), diluted 1:300; anti-vWF (von Willebrand factor; rab-
bit polyclonal antibody, Dako Japan, Japan), diluted
1:300; and anti-human Olig2 (rabbit IgG, Immuno-Bio-
logical Laboratories, Japan), diluted 1:250.
Oligodendrocyte cultures
Primary rat oligodendrocytes were prepared from the cer-
ebral cortices of zi/zi or SD rats at postnatal day 1 using a
shaking method [64]. Briefly, forebrains free of meninges
were chopped into 1 mm3 blocks and placed into HBSS
containing 0.25% trypsin and 10 μg/ml DNase. After
digestion for 15 min at 37°C, the tissue was collected by
centrifugation and triturated in DMEM medium contain-
ing 10% fetal bovine serum, 40 IU/ml penicillin and 40
μg/ml streptomycin, and passed through a 70 μm sieve.
Cells were plated onto poly-D-lysine-coated 25 cm2 flasks
at a density of 1 pup brain per flask. Cultures were fed
with fresh DMEM medium every other day for 10–11 d at
37°C in a humid atmosphere of 5% CO2. To isolate oli-
godendrocytes and oligodendrocyte precursor cells
(OPCs), mixed glial cultures were shaken for 1 hr in an
orbital shaker at 150 rpm at 37°C to remove adherent
microglia/macrophages, and the cultures were washed
with the same medium and subjected to continuous shak-
ing at 220 rpm for 16 hr to separate OPCs from the astro-
cyte layer. The suspension was plated onto uncoated Petri
dishes and incubated for 1 hr at 37°C to further remove
residual microglia and astrocytes adhering to the dishes.
The OPCs were then collected by passing through a nylon
mesh, followed by centrifugation. Isolated OPCs were
plated onto poly-D-lysine-coated (100 μg/ml) glass cover-
slips in 24-well plates at a cell density of 2.0 × 104 cells per
well for morphological and immunocytochemical stud-
ies. Purified OPCs were cultured for 7–8 d in a serum-free
glial defined medium (GDM: DMEM, 0.1% bovine serum
albumin (Roche Diagnostics), 50 μg/ml apo-transferrin
(Sigma), 50 μg/ml insulin (Invitrogen), 30 nM sodium
selenite (Sigma), 10 nM putrescin (Sigma), 10 nM D-
biotin (Sigma), 20 nM progesterone (Sigma), 10 nM
hydrocortisone (Sigma)), supplemented with 5 ng/ml
platelet-derived growth factor (PDGFAA) (R&D systems,
Minneapolis, MN) and 10 ng/ml basic fibroblast growth
factor (bFGF) (R&D systems). At 7–8 d, the cultures were
composed primarily of progenitors and pre-oligodendro-
cytes (A2B5+, O4-, GalC-). After 7 d, the culture medium
was changed to serum-free GDM medium containing 5
ng/ml ciliary neurotrophic factor (CNTF) and 15 nM 3, 3,
5-triiodo-L-thyronine (T3) for 7 additional days until cells
were differentiated into mature oligodendrocytes. Prolif-
erating OPCs or mature oligodendrocytes were fixed with
4% PFA and immunostained with A2B5 or GalC (O1)
antibodies.
RNA extraction and semi-quantitative RT-PCR assay of 
cytokine and chemokine mRNAs
At each time point, zi/zi or zi/+ control rats (n = 3 respec-
tively) were killed and whole brains were rapidly dissected
and frozen in liquid nitrogen. Total RNA was extracted
using TRIzol reagent (Invitrogen Corp., Carlsbad, CA)
according to the manufacturer's instructions and quanti-
fied spectrophotometrically. Three micrograms of total
RNA was reverse-transcribed according to the manufac-
turer's protocol (Superscript II, Invitrogen) using random
primers, and the cDNA prepared from 30 ng of RNA was
subjected to PCR. The primers for rat cytokines were syn-
thesized based on rat cDNA seqeunces for TNF-α (Gen-
Bank accession number: 82524821), IL-1β (204905), IL-6
(2170752), TGF-β (11024651), IFN-γ (24475821), CCL5
(RANTES)(124286795), MIP-1α (CCL3) (40254793),
MCP-1 (CCL2) (13928713), MIP-2 (CXCL2)
(16758459), CXCR4 (82617587), CXCL12 (76496502),
GRO-1 (CXCL1) (13540651), CD26 (DPP4) (6978772),
CXCR3 (16758151) and GAPDH (9798637) as an inter-
nal control. All primer pairs spanned at least one intron in
the corresponding genomic DNA. The sequences of oligo-
nucleotide primers and predicted cDNA sizes were as fol-
lows: IL-1β, sense 5'-CAAGCACCTTCTTTTCCTTCATC-3'
and antisense 5'-GTCGTTGCTTGTCTCTCCTTGTA-3'
(241 bp); TNF-α, sense 5'-CCCAGACCCTCACACTCA-
GAT-3' and antisense 5'-TTGTCCCTTGAAGAGAACCTG-
3'(215 bp); INF-γ, sense 5'-GCCAAGGCACACTCATT-
GAA-3' and antisense 5'-GCTGGTGAATCACTCTGATG-3'
(360 bp); IL-6, sense 5'-CAAGAGACTTC-
CAGCCAGTTGC-3' and antisense 5'-TTGCCGAGTAGAC-
CTCATAGTGACC-3' (101 bp); TGF-β, sense 5'-
GAGAGCCCTGGATACCAACTACTG-3'and antisense 5'-
GTGTGTCCAGGCTCCAAATGTAG-3' (173 bp); GAPDH,
sense 5'-ACCACCATGGAGAAGGCTGG-3' and antisense
5'-CTCAGTGTAGCCCAGGATGC-3' (528 bp); CCL5
(RANTES), sense 5'-CTCCAACCTTGCAGTCGTCT-3' and
antisense 5'-GCCTGTGAAGAGCACACCTC-3' (296 bp);
MIP-1α (CCL3), sense 5'-TGCTGTTCTTCTCTGCACCA-3'
and antisense 5'-GGCTACTTGGCAGCAAACAG-3' (380
bp); MCP-1 (CCL2), sense 5'-TGTAGCATCCACGTGCT-
GTC-3' and antisense 5'-GCTTGAGGTGGTTGTGGAAA-3'
(362 bp); MIP-2 (CXCL2), sense 5'-TCAATGCCTGAC-
GACCCTAC-3' and antisense 5'-ACTCAGACAGCGAG-
GCACAT-3' (308 bp); CXCR4, sense 5'-
GTTTGGTGCTCCGGTAGCTA-3' and antisense 5'-CCA-
GAAGGGGAGTGTGATGA-3' (317 bp); CXCL12 (SDF-
1α), sense 5'-GCTCTGCATCAGTGACGGTA-3' and anti-
sense 5'-CTTTGTGCTGGCAAATCTCAG-3' (382 bp);
GRO-1 (CXCL1), sense 5'-AGACAGTGGCAGGGAT-
TCAC-3' and antisense 5'-GAACGACCATCGATGAAACG-
3' (375 bp); CD26 (DPP4), sense 5'-GCCTGGGTTTCA-
GAAGACAGA-3' and antisense 5'-CTGGAACTGGCAGAT-
GTGTTTG-3 (254 bp); and CXCR3, sense 5'-
ACAAGTGCCAAAGGCAGAGAAG-3' and antisense 5'-BMC Neuroscience 2008, 9:35 http://www.biomedcentral.com/1471-2202/9/35
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GAGCAGGAAGGTGTCTGTGCT-3' (350 bp). For semi-
quantitative PCR, target sequences were amplified by
20–35 cycles of PCR (denaturation at 94°C for 30 sec,
annealing at 58°C for 30 sec, and extension at 72°C for
30 sec) using a GeneAmp 9700 thermal cycler (Applied
Biosystems Japan, Tokyo Japan). The number of amplifi-
cation cycles was optimized to ensure that PCR products
were quantified during the exponential phase of the
amplification. A 10 μl aliquot of each PCR product was
size-separated by electrophoresis on a 2% agarose gel and
stained with ethidium bromide. The gels were photo-
graphed, and the bands were quantified using Image J
1.36 software for Macintosh computers and normalized
to the values for the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH).
Enhanced Perls' staining for ferric iron
Iron distribution in zi/zi or control brains was examined
using the enhanced Perls' method with a minor modifica-
tion [51]. Free-floating brain sections were incubated in
Perl's solution (a 1:1 mixture of 2% potassium ferrocya-
nide and 2% HCl) for 30 minutes, washed in distilled
water, and immersed for 15 min in 0.05% DAB in 0.1 M
phosphate buffer (pH 7.4). One ml of 1% hydrogen per-
oxide was then added for every 200 ml of DAB solution,
and sections were incubated in the solution for 15 min.
After being rinsed with distilled water for 30 min, sections
were mounted on glass slides, lightly counterstained with
0.1% methyl-green or Nissl (0.1% cresyl violet). Some
sections were further processed for electron microscopy.
Electron microscopy
Iron-stained sections were subdissected into smaller rec-
tangular portions that included fields of the substantia
nigra within the midbrain. The sections were osmicated
with 1% osmium tetroxide solution buffered with 0.05 M
phosphate buffer for 2 h and embedded in Epon 812 after
dehydration with a graded ethanol series. The specimens
were cut using an ultramicrotome and observed using a
JEM 2000EX electron microscope (JOEL. Ltd., Japan) after
staining with uranyl acetate and lead hydroxide.
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